Jan 28, 2015
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.19 to $0.01.
The split itself did not change the total investment value.
Cytocom, Inc. (CBLI) trades on the NASDAQ Capital Market in the Biotechnology industry.
Cytocom, Inc. company overviewThe latest split shown was on January 28, 2015. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on January 28, 2015.